Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Berberine alters gut microbial function through modulation of bile acids. β
Go to Publication β
BMC microbiology (BMC Microbiol ) Vol: 21 Issue 1 Pages: 24 Pub: 2021 Jan 11 Epub: 2021 Jan 11 Authors Wolf PG , Devendran S , Doden HL , Ly LK , Moore T , Takei H , Nittono H , Murai T , Kurosawa T , Chlipala GE , Green SJ , Kakiyama G , Kashyap P , McCracken VJ , Gaskins HR , Gillevet PM , Ridlon JM , |
|
|
Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis. β
Go to Publication β
In vivo (Athens, Greece) (In Vivo ) Vol: 37 Issue 5 Pages: 2105-2127 Pub: 2023 Sep-Oct Epub: Authors Chen D , Xiong J , Chen G , Zhang Z , Liu Y , Xu J , Xu H , |
|
|
Preventive effects of a nutraceutical mixture of berberine, citrus and apple extracts on metabolic disturbances in Zucker fatty rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 19 Issue 7 Pages: e0306783 Pub: 2024 Epub: 2024 Jul 26 Authors Siliman Misha M , Destrumelle S , Le Jan D , Mansour NM , Fizanne L , Ouguerram K , Desfontis JC , Mallem MY , |
|
|
Berberine alleviates ETEC-induced intestinal inflammation and oxidative stress damage by optimizing intestinal microbial composition in a weaned piglet model. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 15 Issue Pages: 1460127 Pub: 2024 Epub: 2024 Sep 16 Authors Wang Y , Zhang Z , Du M , Ji X , Liu X , Zhao C , Pang X , Jin E , Wen A , Li S , Zhang F , |
|
|
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. β
Go to Publication β
Journal of translational medicine (J Transl Med ) Vol: 14 Issue 1 Pages: 237 Pub: 2016 Aug 5 Epub: 2016 Aug 5 Authors Li M , Shu X , Xu H , Zhang C , Yang L , Zhang L , Ji G , |
|
|
Antibacterial Potential of Biosynthesized Silver Nanoparticles Using Berberine Extract Against Multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. β
Go to Publication β
Indian journal of microbiology (Indian J Microbiol ) Vol: 64 Issue 1 Pages: 125-132 Pub: 2024 Mar Epub: 2023 Nov 27 Authors Tahan M , Zeraatkar S , Neshani A , Marouzi P , Behmadi M , Alavi SJ , Hashemi Shahri SH , Hosseini Bafghi M , |
|
|
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 913378 Pub: 2022 Epub: 2022 Jul 8 Authors Yang S , Cao S , Li C , Zhang J , Liu C , Qiu F , Kang N , |
|
|
Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model. β
Go to Publication β
Journal of endodontics (J Endod ) Vol: 38 Issue 8 Pages: 1114-7 Pub: 2012 Aug Epub: 2012 Jun 7 Authors Xie Q , Johnson BR , Wenckus CS , Fayad MI , Wu CD , |
|
|
The efficacy and underlying mechanisms of berberine in the treatment of recurrent Clostridioides difficile infection. β
Go to Publication β
International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 65 Issue 5 Pages: 107468 Pub: 2025 Feb 20 Epub: 2025 Feb 20 Authors Wang L , Xu T , Wu S , Zhao C , Huang H , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
